Sign In
Get Clay Free →

Suggestions

    Jean-Marc Steens

    Chief Medical Advisor at Abivax

    Professional Background

    Jean-Marc Steens is a distinguished medical professional with extensive experience in the fields of clinical research and public health. His career spans several decades and encompasses a wealth of experience in the pharmaceutical industry, specifically within GlaxoSmithKline (GSK) and its legacy companies. Starting his career as the Area Medical and Regulatory Director for Belgium and the Netherlands at Wellcome, Jean-Marc rapidly advanced his career. Following the formation of GlaxoWellcome, he transitioned to Research Triangle Park (RTP) as the Medical Strategy Head for HIV, where he made significant contributions to HIV research focused on mother-to-child transmission studies in Africa and Asia. His dedication to public health was further exemplified by his role in the establishment of the HIVNAT (HIV Network for Asia and the Pacific) in Bangkok, Thailand.

    As he progressed in his professional journey, Jean-Marc took on roles with increasing responsibility. He served as Director of Clinical Development at GSK Biologicals in Rixensart, Belgium, overseeing the development of HIV vaccines and the clinical progression of MMRV (Priorix-Tetra). In 2002, he joined the GSK International Medical Team as Therapeutic Head for HIV, where he played an integral role in coordinating activities across various regions, connecting with stakeholders, and driving innovative HIV clinical development projects.

    In 2006, Jean-Marc was appointed Area Medical Director for Sub-Saharan Africa, where he oversaw medical and clinical research activities for all GSK products across the region. His expertise and leadership were recognized in 2009 when he became Vice President and Head of International Medical for ViiV Healthcare, a company borne from the HIV efforts of both GSK and Pfizer. Under his leadership, significant advances were made in HIV treatment and care initiatives.

    In 2015, Jean-Marc transitioned to the biotech sector as Chief Medical Officer at French company ABIVAX. Here, he focused on developing ABX464, initially targeting HIV before extending its application to ulcerative colitis. In March 2021, he was appointed Chief Medical Advisor at ABIVAX, continuing his impactful work in medical strategy and research.

    Education and Achievements

    Jean-Marc’s academic journey began at the renowned Université catholique de Louvain, where he studied medicine and obtained his Medical Doctor Degree, graduating Magna cum Laude. He furthered his education with a Post Doctoral degree in Public Health at the same institution, solidifying his foundation in healthcare and its socio-economic implications. His educational background provided him with the necessary knowledge and skills to excel in his subsequent professional roles and to contribute meaningfully to public health advancements.

    Notable Contributions

    Throughout his career, Jean-Marc has made substantial contributions to clinical research and public health, particularly in the field of HIV/AIDS. His work has not only focused on drug development but has also included efforts in improving access to healthcare in underserved populations, collaborations with local communities, and engaging in numerous advisory boards and steering committees, such as Treat Asia and CIPRA-South Africa.

    Jean-Marc is fluent in multiple languages, including French, Flemish, German, English, and Italian, which enables him to engage effectively with diverse populations in his international roles. His breadth of communication skills, coupled with his rigorous medical training and rich professional experience, positions him as a leading figure in the quest for innovative solutions in public health.

    Legacy and Future Direction

    As a thought leader and medical expert, Jean-Marc Steens continues to influence the landscape of HIV research and treatment. His ongoing work as Chief Medical Advisor at ABIVAX reflects his commitment to advancing novel therapeutic approaches and improving health outcomes in affected populations. His dedication to fostering partnerships, both locally and internationally, signifies his strong belief in collaborative efforts to mitigate public health challenges.

    In conclusion, Jean-Marc Steens' journey through the realms of medical science and public health showcases a remarkable dedication to improving global health outcomes. Through his work in prestigious organizations and his relentless pursuit of clinical excellence, he stands as a beacon of hope for advancing HIV treatment and addressing the critical health issues that persist in today's world. The caliber of his leadership and commitment to innovation makes him a key player in the ongoing fight against HIV and related health challenges.

    Achievements

    Related Questions

    How did Jean-Marc Steens contribute to the establishment of HIVNAT in Bangkok, Thailand?
    What strategies did Jean-Marc Steens employ to enhance collaborative studies in HIV clinical development?
    What was Jean-Marc Steens' role in the clinical development of MMRV (Priorix-Tetra)?
    How has Jean-Marc Steens' multilingual abilities benefited his international medical career?
    What are the key developments in HIV treatment that Jean-Marc Steens has been a part of during his tenure at ViiV Healthcare?
    How does Jean-Marc Steens envision the future of HIV treatment and public health initiatives?
    Jean-Marc Steens
    Add to my network

    Location

    Paris, Île-de-France, France